- Home
- GCTK vs BDRX Comparison
GCTK vs BDRX Comparison
Compare GCTK & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCTK | BDRX |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.8M |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GCTK | BDRX |
|---|---|---|
| Price | $1.58 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 205.9K | 174.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17910.53 | N/A |
| EPS | ★ 30.09 | N/A |
| Revenue | ★ $589,462.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.05 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.09 | $0.79 |
| 52 Week High | $15.90 | $11.88 |
Technical Indicators
Market Signals| Indicator | GCTK | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 25.95 | 32.74 |
| Support Level | $1.52 | $1.03 |
| Resistance Level | $4.24 | $1.29 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 24.48 | 20.65 |
Price Performance
Historical ComparisonAbout GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.